YPSOMED HLDG revenue breakdown overview

YPSOMED HLDG revenue for the last year amounted to 548.46 M CHF, the most of which — 385.15 M CHF — came from its highest performing source at the moment, Ypsomed Delivery Systems, the year earlier bringing 307.81 M CHF. The greatest contribution to the revenue figure was made by Europe — last year it brought YPSOMED HLDG 332.59 M CHF, and the year before that — 308.88 M CHF.